Drugs to prevent COVID-19: A WHO living guideline

Published by Dr Francois Lamontagne and Dr Michael Jacobs (GDG co-chairs) on Mar 2, 2021

Disclaimer

© World Health Organization 2021. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence: https://creativecommons.org/licenses/by-nc-sa/3.0/igo
 

Sponsors

This guideline has been developed by the World Health Organisation (WHO) with methodological support from the MAGIC Evidence Ecosystem Foundation. It has been published as WHO guidance. No specific funding has been provided beyond in-kind resources by the organisations involved, including the BMJ.

Contact

Abstract

Language

en

PICOS

PICO 1.1

Population
Individuals who do not have COVID-19
Intervention
Hydroxychloroquine
Comparator
Standard care
Outcomes